Zurcher Kantonalbank (Zurich Cantonalbank) - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8
-100.0%
6
-100.0%
0.00%
Q2 2023$32,460
+0.3%
18,134
+117.9%
0.00%
Q1 2023$32,369
-20.8%
8,321
-30.8%
0.00%
Q4 2022$40,861
-28.3%
12,018
+15.7%
0.00%
Q3 2022$57,000
+21.3%
10,3900.0%0.00%
Q2 2022$47,000
-39.7%
10,390
-2.4%
0.00%
Q1 2022$78,000
+105.3%
10,641
+78.0%
0.00%
Q4 2021$38,000
+8.6%
5,9770.0%0.00%
Q3 2021$35,000
-43.5%
5,9770.0%0.00%
Q2 2021$62,000
-1.6%
5,9770.0%0.00%
Q1 2021$63,000
-32.3%
5,9770.0%0.00%
-100.0%
Q4 2020$93,000
+6.9%
5,9770.0%0.00%0.0%
Q3 2020$87,000
-23.0%
5,9770.0%0.00%0.0%
Q2 2020$113,000
-1.7%
5,9770.0%0.00%0.0%
Q1 2020$115,000
+53.3%
5,977
+53.7%
0.00%0.0%
Q4 2019$75,000
+102.7%
3,8880.0%0.00%
Q3 2019$37,000
+60.9%
3,8880.0%0.00%
Q2 2019$23,0000.0%3,8880.0%0.00%
Q1 2019$23,000
-36.1%
3,8880.0%0.00%
Q4 2018$36,000
-45.5%
3,8880.0%0.00%
-100.0%
Q3 2018$66,0000.0%3,8880.0%0.00%0.0%
Q2 2018$66,0003,8880.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders